Ivan Budnik Awarded AHA Postdoctoral Fellowship! Aiming to Improve DVT Long-term Outcomes
Ivan Budnik, Postdoctoral Research Scholar at The University of Iowa, shared on LinkedIn:
”I’m delighted to share that I’ve been awarded a two-year American Heart Association Postdoctoral Fellowship (2026–2027)!
Project: Metabolic reprogramming to enhance venous thrombus resolution and mitigate fibrotic vein wall injury.
I’m deeply thankful to my mentor, Dr. Anil Chauhan, for the opportunity to pursue this project and for his guidance along the way; to my lab members for an outstanding scientific environment; and to the leaders in the field who generously provided letters of support.
Thank you to the American Heart Association and the reviewers for valuing this work, which aims to improve long-term outcomes after deep vein thrombosis.”
More winner stories featured in Hemostasis Today.
-
Mar 16, 2026, 19:16Maha Othman: Delighted to See Our Article Receive The Eberhard F. Mammen Most Popular Article Award 2026
-
Mar 16, 2026, 19:03Limited Evidence for Anticoagulation Despite High VTE Risk in Sickle Cell Disease – RPTH
-
Mar 16, 2026, 18:59Bartosz Hudzik: Choosing The Right Anticoagulant for Acute Venous Thromboembolism
-
Mar 16, 2026, 18:54Michael Recht Appointed Chief Medical and Scientific Advisor to NBDF’s Pathway to Cures
-
Mar 16, 2026, 18:46David McIntosh: Moving Beyond Doubts and Ensuring the Safety of Plasma Donation
-
Mar 16, 2026, 18:42Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke
-
Mar 16, 2026, 18:27Christina (Tina) P: Help Advance Research and Support Patients with Antiphospholipid Syndrome
-
Mar 16, 2026, 18:20Ahmed Koriesh: Stroke Prevention in the New 2026 ACC/AHA Dyslipidemia Guideline
-
Mar 16, 2026, 18:13Nameer Ascandar: Outcomes After GI Bleeding in Patients with Rheumatoid Arthritis and AF on Long-Term Oral Anticoagulation